Abstract
Background Neurodevelopmental impairments are common in children with congenital heart disease. The Cardiac Neurodevelopmental Outcome Collaborative and Pediatric Cardiac Critical Care Consortium registry linkage allows for the analysis of associations between neurodevelopmental, medical, and sociodemographic variables in a large contemporary cohort.
Methods Children with congenital heart disease who required surgery with cardiopulmonary bypass at <12 months of age and completed a neurodevelopmental assessment between 11-30 months of age from 2019-2022 were included. Multivariable regression modeling was performed to identify differences in Cognitive, Language, and Motor standard scores from the Bayley Scales of Infant and Toddler Development-III/4 based on congenital cardiac diagnosis, clinical risk factors, and social drivers of health.
Results Primary analyses included 942 assessments from 868 children completed at 25 sites. Across cardiac diagnostic groups, those with genetic diagnoses (n=116 assessments) scored >1 standard deviation lower on all Bayley indices than those without (P<0.001 for each). For those without genetic diagnoses, there were differences between cardiac diagnostic groups (P<0.001) in both Cognitive and Motor indices; participants with transposition of the great arteries exhibited the highest scores compared with other cardiac diagnoses. Lower birth weight, male sex, older age at initial surgery, longer hospital length of stay, more cardiac catheterizations, and lower primary caregiver education were independently associated with worse performance in all indices.
Conclusions Findings from this multicenter cohort demonstrate variation in neurodevelopmental outcomes according to cardiac diagnosis. Regardless of cardiac diagnosis, the presence of a genetic diagnosis is associated with lower neurodevelopmental scores. Heterogeneous outcomes reinforce the importance of surveillance for all infants undergoing heart surgery in the first year of life.
What is new?
While genetic diagnoses confer the highest risk of developmental delays and disorders in patients with CHD, cardiac diagnosis also impacts early neurodevelopmental outcomes in non-syndromic patients.
In non-syndromic patients, those with transposition of the great arteries exhibit higher scores on early ND testing than other common CHD subtypes, while those with single ventricle physiology and atrioventricular septal defects exhibit lower scores.
Older age at surgery and greater number of interventional cardiac catheterizations may represent newly identified risk factors for adverse early ND outcomes in infants with CHD.
What are the clinical implications?
Data from the CNOC registry emphasizes the importance of ND follow-up for all infants undergoing cardiac surgery, including those with simpler CHD subtypes.
The improved outcomes we observed in patients with transposition of the great arteries suggest advances in routine clinical management, including early surgery, may have had a neuroprotective influence.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No external funding recieved
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Michigan Institutional Review Board
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data available upon request
Non-standard Abbreviations and Acronyms
- AVSD
- atrioventricular septal defect
- CHD
- congenital heart disease
- CNOC
- Cardiac Neurodevelopmental Outcome Collaborative
- COA
- coarctation of the aorta
- COI
- Child Opportunity Index
- D-TGA
- dextro-transposition of the great arteries
- ECMO
- extracorporeal membrane oxygenation
- HLHS
- hypoplastic left heart syndrome
- MRI
- magnetic resonance imaging
- ND
- neurodevelopmental
- PC4
- Pediatric Cardiac Critical Care Consortium
- STAT
- Society of Thoracic Surgeons-European Association for Cardio-Thoracic Surgery
- SVP
- single ventricle physiology
- TOF
- tetralogy of Fallot
- VSD
- ventricular septal defect
